HomeTrialNCT05866627
🔬NCT05866627Phase 1RECRUITING

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

Study Summary

The purpose of this study is to confirm there is no significant effect of gastric pH changes of famotidine on the drug levels of afimetoran in healthy participants.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment76 participants
Primary Completion
Lead SponsorBristol-Myers Squibb
Data Retrieved2026-04-11 04:08:14.746858+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.